<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>21(1)</volume><submitter>Bemer P</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Recent studies report very low adherence of practitioners to ATS/IDSA recommendations for the treatment of nontuberculous mycobacteria pulmonary disease (NTM-PD), as well as a great variability of practices. Type of management could impact prognosis.&lt;h4>Methods&lt;/h4>To evaluate management and prognosis of patients with NTM-PD cases with respect to ATS recommendations, we conducted a multicenter retrospective cohort study (18 sentinel sites distributed throughout France), over a period of six years. We collected clinical, radiological, microbiological characteristics, management and outcome of the patients (especially death or not).&lt;h4>Results&lt;/h4>477 patients with NTM-PD were included. Respiratory comorbidities were found in 68% of cases, tuberculosis sequelae in 31.4% of</pubmed_abstract><journal>BMC pulmonary medicine</journal><pagination>333</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8549171</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Management of patients with pulmonary mycobacteriosis in France: a multicenter retrospective cohort study.</pubmed_title><pmcid>PMC8549171</pmcid><pubmed_authors>Couetdic G</pubmed_authors><pubmed_authors>Canis F</pubmed_authors><pubmed_authors>Georges M</pubmed_authors><pubmed_authors>Segonds C</pubmed_authors><pubmed_authors>Vachee A</pubmed_authors><pubmed_authors>Devouassoux G</pubmed_authors><pubmed_authors>Koebel C</pubmed_authors><pubmed_authors>Carriere C</pubmed_authors><pubmed_authors>Godet C</pubmed_authors><pubmed_authors>Caparros D</pubmed_authors><pubmed_authors>Couturaud F</pubmed_authors><pubmed_authors>Boutoille D</pubmed_authors><pubmed_authors>Bourgoin A</pubmed_authors><pubmed_authors>Patry I</pubmed_authors><pubmed_authors>Bador J</pubmed_authors><pubmed_authors>Balavoine C</pubmed_authors><pubmed_authors>Guet-Revillet H</pubmed_authors><pubmed_authors>Andrejak C</pubmed_authors><pubmed_authors>Murris M</pubmed_authors><pubmed_authors>Dumitrescu O</pubmed_authors><pubmed_authors>Vergnon JM</pubmed_authors><pubmed_authors>Beltramo G</pubmed_authors><pubmed_authors>Schramm F</pubmed_authors><pubmed_authors>Blanc FX</pubmed_authors><pubmed_authors>Hery-Arnaud G</pubmed_authors><pubmed_authors>Raskine L</pubmed_authors><pubmed_authors>Basille D</pubmed_authors><pubmed_authors>Dupuy-Grasset M</pubmed_authors><pubmed_authors>Sicard D</pubmed_authors><pubmed_authors>Terru D</pubmed_authors><pubmed_authors>Hamdad-Daoudi F</pubmed_authors><pubmed_authors>Blanchard E</pubmed_authors><pubmed_authors>Cambau E</pubmed_authors><pubmed_authors>Perouse de Montclos M</pubmed_authors><pubmed_authors>Boulanger S</pubmed_authors><pubmed_authors>Dalphin JC</pubmed_authors><pubmed_authors>Godreuil S</pubmed_authors><pubmed_authors>Degot T</pubmed_authors><pubmed_authors>Desquiens M</pubmed_authors><pubmed_authors>Bemer P</pubmed_authors><pubmed_authors>Duez JM</pubmed_authors><pubmed_authors>Guillouzouic A</pubmed_authors><pubmed_authors>Mougari F</pubmed_authors><pubmed_authors>Lanotte P</pubmed_authors><pubmed_authors>Gaudart A</pubmed_authors><pubmed_authors>Martin C</pubmed_authors><pubmed_authors>Lagrange A</pubmed_authors><pubmed_authors>Risso K</pubmed_authors><pubmed_authors>Peuchant O</pubmed_authors><pubmed_authors>Carricajo A</pubmed_authors><pubmed_authors>Marchand-Adam S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Management of patients with pulmonary mycobacteriosis in France: a multicenter retrospective cohort study.</name><description>&lt;h4>Background&lt;/h4>Recent studies report very low adherence of practitioners to ATS/IDSA recommendations for the treatment of nontuberculous mycobacteria pulmonary disease (NTM-PD), as well as a great variability of practices. Type of management could impact prognosis.&lt;h4>Methods&lt;/h4>To evaluate management and prognosis of patients with NTM-PD cases with respect to ATS recommendations, we conducted a multicenter retrospective cohort study (18 sentinel sites distributed throughout France), over a period of six years. We collected clinical, radiological, microbiological characteristics, management and outcome of the patients (especially death or not).&lt;h4>Results&lt;/h4>477 patients with NTM-PD were included. Respiratory comorbidities were found in 68% of cases, tuberculosis sequelae in 31.4% of</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Oct</publication><modification>2025-04-04T13:50:56.63Z</modification><creation>2025-04-04T13:50:56.63Z</creation></dates><accession>S-EPMC8549171</accession><cross_references><pubmed>34702233</pubmed><doi>10.1186/s12890-021-01701-5</doi></cross_references></HashMap>